KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Cash from Operations (2016 - 2026)

Pacira BioSciences has reported Cash from Operations over the past 17 years, most recently at 25680000.0 for Q1 2026.

  • For Q1 2026, Cash from Operations fell 27.58% year-over-year to 25680000.0; the TTM value through Mar 2026 reached 142215000.0, down 19.08%, while the annual FY2025 figure was 151994000.0, 19.75% down from the prior year.
  • Cash from Operations for Q1 2026 was 25680000.0 at Pacira BioSciences, down from 43689000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 60834000.0 in Q3 2025 and troughed at 12012000.0 in Q2 2025.
  • A 5-year average of 39234470.59 and a median of 42654000.0 in 2022 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: skyrocketed 156.7% in 2024 and later crashed 77.44% in 2025.
  • Year by year, Cash from Operations stood at 42037000.0 in 2022, then grew by 13.2% to 47584000.0 in 2023, then tumbled by 30.37% to 33132000.0 in 2024, then skyrocketed by 31.86% to 43689000.0 in 2025, then tumbled by 41.22% to 25680000.0 in 2026.
  • Business Quant data shows Cash from Operations for PCRX at 25680000.0 in Q1 2026, 43689000.0 in Q4 2025, and 60834000.0 in Q3 2025.